Registry for aggressive pituitary tumors (Aggressive PitNETs)
Part of Cancer, Hormones & metabolism clinical trials.
This study is a research registry that collects information from people with aggressive pituitary tumors. It may help researchers better understand these tumors by building a large, shared dataset over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosed pituitary tumor (a growth near the brain’s pituitary gland)
- Your medical file has been reviewed/presented to the HYPOcare national program (RCP)
- You are willing to participate (you do not object to being included)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a “registry,” meaning researchers collect health information from people who have surgery for certain hormone-related tumors. It may help doctors better understand outcomes and improve future care for endocrine tumors.
This study looks at stored tumor tissue from people with pituitary neuroendocrine tumors (Pit-NETs). Researchers want to learn more about the tumor's features and how it relates to long-term outcomes.
This study keeps a worldwide record of people with neuroendocrine tumors to learn about care patterns and outcomes. It may help your doctors and future patients by improving how these tumors are monitored and treated.
This is a registry study that collects medical information from adults with neuroendocrine tumors (NETs) that start in the digestive organs. It helps researchers understand these cancers better and may support future studies.
This study looks at whether blood and tissue markers, along with imaging features, can predict how aggressive a pituitary neuroendocrine tumor is and how it may affect long-term health. It aims to improve treatment decisions by better understanding these tumors.
This study creates an international registry linked to a virtual biobank, so researchers can collect and share information and biological samples for patients with specific peripheral neuroblastic tumors. It may help future research and care planning by improving what scientists know about these conditions.
Hear when a new Endocrine Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.